Pattern of Epstein-Barr virus association in childhood non-Hodgkin's lymphoma: Experience of University of Malaya Medical Center

Pathology International

Volumn 54, Issue 3, 2004, Pages 151-157

  Peh, Suat Cheng ^a,b   Madarajah, Veera S ^a   Tai, Yan Chin ^a   Kim, Lian Hua ^a   Abdullah, Wan Ariffin B ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Childhood; Epidemiology; Epstein Barr virus; Non Hodgkin's lymphoma

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALAYSIA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; LYMPHOMA, NON-HODGKIN; MALAYSIA; MALE;

EID: 2542643153     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2003.01601.x     Document Type: Article

References (45)

1. Harrington DS, Ye YL, Weisenburger DD et al. Malignant lymphoma in Nebraska and Guangzhou, China: a comparative study. Hum Pathol 1987; 18: 924-8.
2. Shih LY, Liang DC. Non-Hodgkin's lymphomas in Asia. Hematol Oncol Clin North Am 1991; 5: 983-1001.
3. Ho FCS, Todd D, Loke SL, Ng RP, Khoo RKK. Clinicopathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period. Int J Cancer 1984; 34: 143-8.
4. Ji X, Li W. Malignant lymphomas in Beijing. J Environ Pathol Toxicol Oncol 1992; 11: 327-9.
5. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin's lymphoma classification project. Ann Oncol 1998; 9: 717-20.
6. Jaffe ES, Chan JKC, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis and epidemiology . Am J Surg Pathol 1996; 20: 103-11.
7. Aozasa K, Ohsawa M, Tajima K et al. Nationwide study of lethal midline granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int J Cancer 1989; 44: 63-6.
8. Ho FCS, Choy D, Loke SL et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathological study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 1990; 21: 1041-50.
9. Chan JKC, Ng CS, Lau WH, Lo STH. Most nasal/nasopharyngeal lymphomas are peripheral T-cell lymphomas. Am J Surg Pathol 1987; 11: 418-29.
10. Harabuchi Y, Yamanaka N, Kataura A et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128-80.
11. Chiang AKS, Tao Q, Srivastava G, Ho FCS. Nasal NK and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 1996; 68: 285-90.
12. Arber DA, Weiss LM, Albujar PF, Chen YY, Jaffe ES. Nasal lymphomas in Peru. Am J Surg Pathol 1993; 17: 392-9.
13. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of lymphomas: A work in progress. Ann Oncol 1998; 9: s25-s30.
14. Weiss LM, Gaffey MJ, Chen YY, Frierson HF. Frequency of Epstein-Barr viral DNA in 'Western' sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am J Surg Pathol 1992; 16: 156-62.
15. Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United Stated and their descendants. Cancer Causes Control 1996; 7: 224-30.
16. Peh SC. Host ethnicity influences non-Hodgkin's lymphoma (NHL) subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia. Histopathology 2001; 38: 458-65.
17. Peh SC, Sandvej K, Pallesen G. Epstein-Barr virus (EBV) in Malaysian upper-aerodigestive-tract lymphoma: incidence and subtype. Int J Cancer 1995; 61: 327-32.
18. Agnarsson BA, Kadin ME. Peripheral T-cell lymphoma in children. Semin Diagn Pathol 1995; 12: 314-24.
19. Gall EA, Mallory TB. Malignant lymphoma. A clinico-pathologic survey of 618 cases. Am J Pathol 1942; 18: 381-429.
20. Cossman J, Bernard CW. Histopathology of childhood non-Hodgkin's lymphomas. In: Pole G, ed. Non-Hodgkin's Lymphoma in Children. New York, USA: Masson Publishing, 1980; 13.
21. Wilson JF, Jenkin RDT, Anderson JR et al. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group. Cancer 1984; 53: 1695-704.
22. Nair S, Krishnaswami H. Non-Hodgkin's lymphoma in a South Indian hospital - our experience with the International Working Formulation. Indian J Pathol Microbiol 1990; 33: 17-22.
23. Walter PR, Klotz F, Alfy-Gattas T, Minko-Mi-Etoua D, Nguembi-Mbina C. Malignant lymphomas in Gabon (Equatorial Africa). A morphologic study of 72 cases. Hum Pathol 1991; 22: 1040-43.
24. Atra A, Meller ST, Stevens RS et al. Conservative management of follicular non-Hodgkin's lymphoma in childhood. Br J Haematol 1998; 103: 220-23.
25. Varghese C, Barrett JH, Johnston C, Shires M, Rider L, Forman D. High risk of lymphomas in children of Asian origin: ethnicity or confounding by socioeconomic status? Br J Cancer 1996; 74: 1503-6.
26. Wilkinson JD, Fleming LE, MacKinnon J et al. Lymphoma and lymphoid leukemia incidence in Florida children: ethnic and racial distribution. Cancer 2001; 91: 1402-8.
27. Revesz T, Mpofu C, Oyejide C. Ethnic differences in the lymphoid malignancies of children in the United Amirates. A clue to aetiology? Leukemia 1995; 9: 189-93.
28. McNally RJ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM. Examination of temporal trends in the incidence of childhood leukemias and lymphomas provides aetiological clues. Leukemia 2001; 15: 1612-18.
29. Flavell KJ, Biddulph JP, Powell JE et al. South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease. Br J Cancer 2001; 85: 350-56.
30. Peh SC, Looi LM, Pallesen G. Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia. Histopathology 1997; 30: 227-33.
31. Shiramizu B, Chang CW, Cairo MS. Absence of human herpesvirus 6 genome by polymerase chain reaction in children with Hodgkin disease: a Children's Cancer Group Lymphoma Biology Study. Pediatr Hematol Oncol 2001; 23: 282-5.
32. Baris D, Zahn SH. Epidemiology of lymphomas. Curr Opin Oncol 2000; 12: 383-94.
33. Philip T, Lenoir GM, Bryon PA et al. Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br J Cancer 1982; 45: 670-78.
34. Wright D, McKeever P, Carter R. Childhood non-Hodgkin's lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group. J Clin Pathol 1997; 50: 128-34.
35. Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996; 52: 682-703.
36. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133-270.
37. Tosato G, Taga K, Angiolillo AL, Sgadari C. Epstein-Barr virus as an agent of haematological disease. Baillieres Clin Haematol 1995; 8: 165-99.
38. Shiota M, Nakamura S, Ichiohasama R et al. Anaplastic large cell lymphoma expressing the novel chimaric protein p80NPM/ ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954-60.
39. Gascoyne RD, Aoun P, Wu D et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93: 3913-21.
40. Jevon GP, Elavathil LJ, Harnish DG, deSa DJ. Epstein-Barr virus in non-Hodgkin's lymphomas and lymphoid tissue in children. Pediatr Pathol Lab Med 1995; 15: 283-90.
41. Kanegane H, Wang F, Tosato G. Virus-cell interactions in a natural killer-like cell line from a patient with lymphoblastic lymphoma. Blood 1996; 88: 4667-75.
42. Timens W, Boes H, Poppema S. Tissue distribution of the C3d/ EBV receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry 1991; 95: 605-11.
43. Menezes J, Siegneurin JM, Patel P, Bourkas A, Lenoir G. Presence of Epstein-Barr virus receptors, but absence of virus penetration in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt4). J Virol 1977; 22: 816-21.
44. Tatsumi E, Yoneda N, Kawano S, Yamaguchi N. CD21 antigen in T-lineage neoplastic lymphoid cells: Characteristic expression at thymic stage. Am J Hematol 1994; 45: 150-55.
45. Oshima K, Muta K, Nakashima M et al. Expression of human tumour-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion. Int J Cancer 2001; 93: 91-6.